Randall Moreadith
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Randall W.
Moreadith was the founder of Oxurion NV, founded in 1996, where the titles held included President & Chief Operating Officer from 1996 to 2003.
Current jobs include President, Chief Executive Officer & Director at Serina Therapeutics (AL), Inc. since 2010; President, Chief Executive Officer & Director at Canaria Therapeutics, Inc.; and Chief Development Officer at Serina Therapeutics, Inc. since 2024.
Former jobs include Chief Medical Officer at Renovis, Inc. from 2004 to 2005; Principal Medical Officer at Quintiles, Inc. (California) from 1996 to 1997; Chief Medical Officer at Tissue Repair Co. from 2006 to 2007; Chief Medical Officer at Post-Hypothermia Corp.; Chief Medical Officer & Executive Vice President at Gene Biotherapeutics, Inc. from 2006 to 2008; and Chief Development Officer & SVP-Drug Development at Nektar Therapeutics in 2009.
Education includes doctorate degrees from Duke University and The Johns Hopkins University, and an undergraduate degree from North Carolina State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-05-21 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Verkställande Direktör | 2010-09-01 |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| NEKTAR THERAPEUTICS | Företagsledare/Principal | 2009-12-01 |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Teknisk/Vetenskaplig/F&U Direktör | 2008-01-01 |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Teknisk/Vetenskaplig/F&U Direktör | 2007-01-02 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2005-12-16 |
| OXURION NV | Grundare | 2003-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Oxurion NV
Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Commercial Services |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån